CARGO Therapeutics Files 2025 Proxy Statement
| Field | Detail |
|---|---|
| Company | Cargo Therapeutics, Inc. |
| Form Type | DEF 14A |
| Filed Date | Apr 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, annual-meeting
TL;DR
CARGO proxy filed, vote on directors & auditors June 18.
AI Summary
CARGO Therapeutics, Inc. filed its definitive proxy statement on April 29, 2025, for its annual meeting of stockholders scheduled for June 18, 2025. The filing outlines the company's governance, executive compensation, and proposals to be voted on by shareholders. Key items likely include the election of directors and ratification of independent auditors.
Why It Matters
This filing provides shareholders with crucial information regarding company leadership, compensation, and voting matters, enabling informed participation in corporate governance.
Risk Assessment
Risk Level: low — This is a routine annual filing (DEF 14A) and does not contain new material financial or operational information.
Key Numbers
- 2025 — Fiscal Year End (Indicates the period for which financial reporting is relevant.)
Key Players & Entities
- CARGO Therapeutics, Inc. (company) — Registrant
- 0001966494 (company) — Central Index Key
- June 18, 2025 (date) — Annual Meeting Date
- April 29, 2025 (date) — Filing Date
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information for the annual meeting, including details on director elections, executive compensation, and other corporate governance matters.
When is the CARGO Therapeutics, Inc. annual meeting of stockholders scheduled?
The annual meeting of stockholders is scheduled for June 18, 2025.
What is the filing date of this proxy statement?
This definitive proxy statement was filed on April 29, 2025.
What is the company's Standard Industrial Classification (SIC) code?
The company's SIC code is 2836, which corresponds to BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
Where is CARGO Therapeutics, Inc. headquartered?
CARGO Therapeutics, Inc. is headquartered at 835 Industrial Road, Suite 400, San Carlos, CA 94070.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 29, 2025 regarding CARGO Therapeutics, Inc..